Transition to androgen-independence in prostate cancer
- 7 June 2002
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 81 (3), 191-201
- https://doi.org/10.1016/s0960-0760(02)00064-x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A Dominant-negative Mutant of Androgen Receptor Coregulator ARA54 Inhibits Androgen Receptor-mediated Prostate Cancer GrowthJournal of Biological Chemistry, 2002
- Identification and Characterization of a Novel Androgen Receptor Coregulator ARA267-α in Prostate Cancer CellsJournal of Biological Chemistry, 2001
- Variable expressivity and mutation databases: The androgen receptor gene mutations databaseHuman Mutation, 2001
- Photoaffinity Labeling Identification of a Specific Binding Protein for the Anabolic Steroids Stanozolol and Danazol: An Oligomeric Protein Regulated by Age, Pituitary Hormones, and Ethinyl EstradiolEndocrinology, 2000
- A Novel Androgen-Regulated Gene, PMEPA1, Located on Chromosome 20q13 Exhibits High Level Expression in ProstateGenomics, 2000
- Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA componentOncogene, 2000
- Hormonal carcinogenesisCarcinogenesis: Integrative Cancer Research, 2000
- Isolation of cDNAs that are differentially expressed between androgen‐dependent and androgen‐independent prostate carcinoma cells using differential display PCRThe Prostate, 1995
- In vivo amplification of the androgen receptor gene and progression of human prostate cancerNature Genetics, 1995
- Stanozolol and danazol, unlike natural androgens, interact with the low affinity glucocorticoid-binding sites from male rat liver microsomesEndocrinology, 1994